A detailed history of Jefferies Financial Group Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 366,299 shares of CTLT stock, worth $20.6 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
366,299
Previous 64,900 464.41%
Holding current value
$20.6 Million
Previous $2.92 Million 609.33%
% of portfolio
0.2%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$42.56 - $59.82 $12.8 Million - $18 Million
301,399 Added 464.41%
366,299 $20.7 Million
Q4 2023

Feb 13, 2024

BUY
$32.18 - $46.57 $2.09 Million - $3.02 Million
64,900 New
64,900 $2.92 Million
Q2 2023

Aug 14, 2023

BUY
$31.86 - $67.26 $366,390 - $773,490
11,500 New
11,500 $498,000
Q4 2022

Feb 14, 2023

BUY
$41.39 - $81.0 $465,968 - $911,898
11,258 New
11,258 $506,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.1B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.